Combination Therapy Using Sodium-Glucose CoTransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes

Volume: 2, Issue: 5
Published: Aug 5, 2020
Abstract
The rationale of using a combination of a GLP-1RA plus SGLT- 2 inhibitor relies on many factors. First, these 2...
Paper Details
Title
Combination Therapy Using Sodium-Glucose CoTransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes
Published Date
Aug 5, 2020
Volume
2
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.